IL6 and pulmonary fibrosis: Pulmonary fibrosis (PF) is a chronic and progressive lung disease (1), It is characterized by chronic inflammation, characterized by the release of cytokines such as transforming growth factor beta (TGF-β) and interleukin 6 (IL-6), triggered by repeated alveolar damage.